Caption Management, LLC Fate Therapeutics Inc Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$47.84 - $64.34 $1.15 Million - $1.54 Million	-24,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.27 - $95.73 $1.01 Million - $1.63 Million	17,000 Added 242.86%	24,000 $1.42 Million
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $558,175 - $767,916	-8,300 Reduced 54.25%	7,000 $609,000
Q2 2020 Aug 14, 2020	SELL	$20.21 - $35.23 $634,594 - $1.11 Million	-31,400 Reduced 67.24%	15,300 $524,000
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $115,776 - $213,596	6,700 Added 16.75%	46,700 $1.04 Million
Q4 2019 Feb 13, 2020	BUY	$13.39 - $20.73 $535,600 - $829,200	40,000 New	40,000 $783,000

178

113M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $129M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.